Since 2000, modern science combined with unprecedented local, national and global action has delivered record progress, with malaria deaths cut by over 60%, saving almost seven million lives.
Despite the progress, malaria remains one of the leading causes of childhood death. In 2015 there were over 212 million cases and 429,000 deaths from malaria. Since January 2017, Dentsu Aegis Network have supported Malaria No More to make the big leap towards ending malaria for good.
Our achievements in reducing malaria are not a given and require renewed investment and attention. In particular, the increasing emergence of drug-resistant forms of malaria and insecticide resistant mosquitoes threatens our hard-won progress to date.
Since January 2017 Dentsu Aegis Network have supported Malaria No More to continue the move towards ending malaria for good. The partnership is global and stretches until the end of 2020. The main focus of the partnership is on establishing the “Creative Collective”, an alliance of agencies to help make malaria history.
There have been a wide range of Dentsu Aegis agencies involved with the campaign including Carat, who assisted with initial messaging work; Vizeum, who worked on audience and media planning and Isobar, who created and designed the #MalariaMustDie website. Amplifi and Posterscope were also engaged to deliver pro bono online, print, TV and outdoor media coverage in India, the UK, Nigeria, Kenya and Australia.
Built by a broad alliance of agencies inside and outside Dentsu Aegis Network, the campaign reached 22m people in five countries to exert pressure on political leaders.
This strategy came through when world leaders pledged to halve malaria by 2023 with an additional capital infusion of USD$2.9bn into the Global Fund.
“#MalariaNoMore shows how crucial it is to have the cross-sector engagement and commitments. Dentsu Aegis Network showed that this is not just another siloed charity campaign but one that looks to engage the wider public and business.”Kate Wills, Director of Communications and Partnerships, Malaria No More
World-Changing Technology Campaigns
Multiple Myeloma Customer Centric Multi-Channel Campaign
American Multi-Brand Pharmaceutical Company Increases Oncological Growth Potential by Combining Personal and Digital Promotional Strategies
Myeloid Leukemia Multi-Channel Campaign
Cancer Treatments Pharmaceutical Manufacturer
New Product Launch for Multiple Myeloma (MM) Treatment